C13安定同位体標識生体分子の世界市場

【英語タイトル】Global C13 Stable Isotope Labeled Biomolecules Market Insights, Forecast to 2025

QYResearchが出版した調査資料(WR-057421)・商品コード:WR-057421
・発行会社(調査会社):QYResearch
・発行日:2019年4月
・ページ数:約130
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥897,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

This study categorizes the global C13 Stable Isotope Labeled Biomolecules breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

Global C13 Stable Isotope Labeled Biomolecules market size will increase to xx million US$ by 2025, from xx million US$ in 2018, growing at a CAGR of xx% during 2019-2025.

The following manufacturers are covered in this report:
Thermo Fisher Scientific
Omicron Biochemicals, Inc.
Icon Isotopes
Sigma-Aldrich (Merck)
Medical Isotopes
Cambridge Isotope Laboratories
Sicence Peptide/Amino acid
Innovagen
Antagene, Inc.
AnaSpec
ACRO Biosystems

C13 Stable Isotope Labeled Biomolecules Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

C13 Stable Isotope Labeled Biomolecules Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Rest of Middle East & Africa

C13 Stable Isotope Labeled Biomolecules Breakdown Data by Type:
C13 Labeled Carbohydrates
C13 Labeled Peptide/Amino acid
Others

C13 Stable Isotope Labeled Biomolecules Breakdown Data by Application:
Scientific Research
Medical
Others

【レポートの目次】

1 Study Coverage
1.1 C13 Stable Isotope Labeled Biomolecules Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type
1.4.2 C13 Labeled Carbohydrates
1.4.3 C13 Labeled Peptide/Amino acid
1.4.4 Others
1.5 Market by Application
1.5.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application
1.5.2 Scientific Research
1.5.3 Medical
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Growth Rate
2.1 Global C13 Stable Isotope Labeled Biomolecules Production
2.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue 2014-2025
2.1.2 Global C13 Stable Isotope Labeled Biomolecules Production 2014-2025
2.1.3 Global C13 Stable Isotope Labeled Biomolecules Capacity 2014-2025
2.1.4 Global C13 Stable Isotope Labeled Biomolecules Marketing Pricing and Trends
2.2 C13 Stable Isotope Labeled Biomolecules Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key C13 Stable Isotope Labeled Biomolecules Manufacturers
2.4 Market Drivers, Trends and Issues
3 Market Size by Manufacturers
3.1 C13 Stable Isotope Labeled Biomolecules Production by Manufacturers
3.1.1 C13 Stable Isotope Labeled Biomolecules Production by Manufacturers
3.1.2 C13 Stable Isotope Labeled Biomolecules Production Market Share by Manufacturers
3.1.3 Global Market Concentration Ratio (CR5 and HHI)
3.2 C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers
3.2.1 C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2014-2019)
3.2.2 C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2014-2019)
3.2.3 Global C13 Stable Isotope Labeled Biomolecules Market Concentration Ratio (CR10 and HHI)
3.3 C13 Stable Isotope Labeled Biomolecules Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 C13 Stable Isotope Labeled Biomolecules Production by Regions
4.1 Global C13 Stable Isotope Labeled Biomolecules Production by Regions
4.1.1 Global C13 Stable Isotope Labeled Biomolecules Production Market Share by Regions
4.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Regions
4.2 United States
4.2.1 United States C13 Stable Isotope Labeled Biomolecules Production
4.2.2 United States C13 Stable Isotope Labeled Biomolecules Revenue
4.2.3 Key Players in United States
4.2.4 United States C13 Stable Isotope Labeled Biomolecules Import & Export
4.3 Europe
4.3.1 Europe C13 Stable Isotope Labeled Biomolecules Production
4.3.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue
4.3.3 Key Players in Europe
4.3.4 Europe C13 Stable Isotope Labeled Biomolecules Import & Export
4.4 China
4.4.1 China C13 Stable Isotope Labeled Biomolecules Production
4.4.2 China C13 Stable Isotope Labeled Biomolecules Revenue
4.4.3 Key Players in China
4.4.4 China C13 Stable Isotope Labeled Biomolecules Import & Export
4.5 Japan
4.5.1 Japan C13 Stable Isotope Labeled Biomolecules Production
4.5.2 Japan C13 Stable Isotope Labeled Biomolecules Revenue
4.5.3 Key Players in Japan
4.5.4 Japan C13 Stable Isotope Labeled Biomolecules Import & Export
4.6 Other Regions
5 C13 Stable Isotope Labeled Biomolecules Consumption by Regions
5.1 Global C13 Stable Isotope Labeled Biomolecules Consumption by Regions
5.1.1 Global C13 Stable Isotope Labeled Biomolecules Consumption by Regions
5.1.2 Global C13 Stable Isotope Labeled Biomolecules Consumption Market Share by Regions
5.2 North America
5.2.1 North America C13 Stable Isotope Labeled Biomolecules Consumption by Application
5.2.2 North America C13 Stable Isotope Labeled Biomolecules Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe C13 Stable Isotope Labeled Biomolecules Consumption by Application
5.3.2 Europe C13 Stable Isotope Labeled Biomolecules Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Consumption by Application
5.4.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America C13 Stable Isotope Labeled Biomolecules Consumption by Application
5.5.2 Central & South America C13 Stable Isotope Labeled Biomolecules Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Consumption by Application
5.6.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Consumption by Countries
5.6.3 GCC Countries
5.6.4 Egypt
5.6.5 South Africa
6 Market Size by Type
6.1 Global C13 Stable Isotope Labeled Biomolecules Breakdown Dada by Type
6.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type
6.3 C13 Stable Isotope Labeled Biomolecules Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global C13 Stable Isotope Labeled Biomolecules Breakdown Dada by Application
8 Manufacturers Profiles
8.1 Thermo Fisher Scientific
8.1.1 Thermo Fisher Scientific Company Details
8.1.2 Thermo Fisher Scientific Description
8.1.3 Thermo Fisher Scientific Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.1.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Description
8.1.5 Thermo Fisher Scientific SWOT Analysis
8.2 Omicron Biochemicals, Inc.
8.2.1 Omicron Biochemicals, Inc. Company Details
8.2.2 Omicron Biochemicals, Inc. Description
8.2.3 Omicron Biochemicals, Inc. Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.2.4 Omicron Biochemicals, Inc. C13 Stable Isotope Labeled Biomolecules Product Description
8.2.5 Omicron Biochemicals, Inc. SWOT Analysis
8.3 Icon Isotopes
8.3.1 Icon Isotopes Company Details
8.3.2 Icon Isotopes Description
8.3.3 Icon Isotopes Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.3.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Description
8.3.5 Icon Isotopes SWOT Analysis
8.4 Sigma-Aldrich (Merck)
8.4.1 Sigma-Aldrich (Merck) Company Details
8.4.2 Sigma-Aldrich (Merck) Description
8.4.3 Sigma-Aldrich (Merck) Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.4.4 Sigma-Aldrich (Merck) C13 Stable Isotope Labeled Biomolecules Product Description
8.4.5 Sigma-Aldrich (Merck) SWOT Analysis
8.5 Medical Isotopes
8.5.1 Medical Isotopes Company Details
8.5.2 Medical Isotopes Description
8.5.3 Medical Isotopes Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.5.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Description
8.5.5 Medical Isotopes SWOT Analysis
8.6 Cambridge Isotope Laboratories
8.6.1 Cambridge Isotope Laboratories Company Details
8.6.2 Cambridge Isotope Laboratories Description
8.6.3 Cambridge Isotope Laboratories Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.6.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Description
8.6.5 Cambridge Isotope Laboratories SWOT Analysis
8.7 Sicence Peptide/Amino acid
8.7.1 Sicence Peptide/Amino acid Company Details
8.7.2 Sicence Peptide/Amino acid Description
8.7.3 Sicence Peptide/Amino acid Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.7.4 Sicence Peptide/Amino acid C13 Stable Isotope Labeled Biomolecules Product Description
8.7.5 Sicence Peptide/Amino acid SWOT Analysis
8.8 Innovagen
8.8.1 Innovagen Company Details
8.8.2 Innovagen Description
8.8.3 Innovagen Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.8.4 Innovagen C13 Stable Isotope Labeled Biomolecules Product Description
8.8.5 Innovagen SWOT Analysis
8.9 Antagene, Inc.
8.9.1 Antagene, Inc. Company Details
8.9.2 Antagene, Inc. Description
8.9.3 Antagene, Inc. Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.9.4 Antagene, Inc. C13 Stable Isotope Labeled Biomolecules Product Description
8.9.5 SWOT Analysis
8.10 AnaSpec
8.10.1 AnaSpec Company Details
8.10.2 AnaSpec Description
8.10.3 Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.10.4 AnaSpec C13 Stable Isotope Labeled Biomolecules Product Description
8.10.5 AnaSpec SWOT Analysis
8.11 ACRO Biosystems
8.11.1 ACRO Biosystems Company Details
8.11.2 ACRO Biosystems Description
8.11.3 Capacity, Production and Value of C13 Stable Isotope Labeled Biomolecules
8.11.4 ACRO Biosystems C13 Stable Isotope Labeled Biomolecules Product Description
8.11.5 ACRO Biosystems SWOT Analysis
9 Production Forecasts
9.1 C13 Stable Isotope Labeled Biomolecules Production and Revenue Forecast
9.1.1 Global C13 Stable Isotope Labeled Biomolecules Production Forecast 2019-2025
9.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast 2019-2025
9.2 C13 Stable Isotope Labeled Biomolecules Production and Revenue Forecast by Regions
9.2.1 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Regions
9.2.2 Global C13 Stable Isotope Labeled Biomolecules Production Forecast by Regions
9.3 C13 Stable Isotope Labeled Biomolecules Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global C13 Stable Isotope Labeled Biomolecules Production Forecast by Type
9.4.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Country 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Country 2019-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Country 2019-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Country 2019-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Consumption Forecast by Country 2019-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of C13 Stable Isotope Labeled Biomolecules Upstream Market
11.1.1 C13 Stable Isotope Labeled Biomolecules Key Raw Material
11.1.2 Typical Suppliers of Key C13 Stable Isotope Labeled Biomolecules Raw Material
11.1.3 C13 Stable Isotope Labeled Biomolecules Raw Material Market Concentration Rate
11.2 C13 Stable Isotope Labeled Biomolecules Industry Chain Analysis
11.3 Marketing & Distribution
11.4 C13 Stable Isotope Labeled Biomolecules Distributors
11.5 C13 Stable Isotope Labeled Biomolecules Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer



★調査レポート[C13安定同位体標識生体分子の世界市場] (コード:WR-057421)販売に関する免責事項を必ずご確認ください。
★調査レポート[C13安定同位体標識生体分子の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆